Skip to main content
logo
BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.600
-0.150 (-4.00%)
At close: Jul 22, 2026, 4:00 PM EDT
3.513
-0.087 (-2.41%)
After-hours: Jul 22, 2026, 7:34 PM EDT

BriaCell Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Net Income
-30.98-26.56-4.93-20.3-26.84-13.82
Depreciation & Amortization
0.120.110.080.020.020.02
Stock-Based Compensation
1.010.781.82.193.071.97
Other Adjustments
-0.7-0.59-28.14-2.1211.666.36
Change in Receivables
-0.73-0.730.01-0.010.01
Changes in Accounts Payable
-1.93-3.896.050.660.25-1.41
Changes in Accrued Expenses
0.360.75-0.390.20.14-0.79
Changes in Other Operating Activities
-0.220.492.13-4.4-0.76-0.1
Operating Cash Flow
-30.82-28.17-24.13-23.74-12.48-7.75
Capital Expenditures
---0.46---
Purchases of Investments
-23.1-7.32----
Other Investing Activities
-0.34-0.33-0.23---
Investing Cash Flow
-23.43-7.65-0.68---
Short-Term Debt Repaid
------0.24
Net Short-Term Debt Issued (Repaid)
------0.24
Long-Term Debt Issued
-----0.22
Long-Term Debt Repaid
------0.31
Net Long-Term Debt Issued (Repaid)
------0.09
Issuance of Common Stock
41.4345.454.4246.5165.33
Repurchase of Common Stock
----0.05-10.17-
Net Common Stock Issued (Repurchased)
41.4345.454.423.95-3.6665.33
Other Financing Activities
-----0.08-
Financing Cash Flow
41.4345.454.423.95-3.7465
Net Cash Flow
-5.589.63-20.39-19.79-16.2357.25
Free Cash Flow
-30.82-28.17-24.58-23.74-12.48-7.75
Free Cash Flow Per Share
-9.62-66.58-224.09-228.03-120.86-257.22
Levered Free Cash Flow
-32.34-28.852.62-23.82-27.2-16.42
Unlevered Free Cash Flow
-31.29-29.74-25.92-26.79-15.65-9.25
SEC Filings: 10-K · 10-Q